Acciones Isodiol International Inc Other OTC
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 17,61 M | Ventas 2019 | 22,25 M 20,47 M | Capitalización | 49,96 M 45,97 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -33,13 M | Resultado Neto 2019 | -126 M -116 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 14,31 M | Deuda neta 2019 | 5,22 M 4,81 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,38 % | 6261,52 M | |
-15,86 % | 4490,29 M | |
+6,36 % | 3285,57 M | |
-11,28 % | 3123,64 M | |
-3,23 % | 2496,83 M | |
+45,24 % | 1940,45 M | |
-7,89 % | 1684,98 M | |
-0,98 % | 1634,88 M | |
-11,32 % | 1564,08 M |